Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.
(Sharecast News) - Advanced Medical Solutions reported robust first-half revenue growth on Tuesday, supported by strong momentum in its core surgical portfolio and early commercial synergies from recent acquisitions.
Group revenue was expected to be £110m for the six months ended 30 June, up from £68m a year earlier.
Adjusted EBITDA was forecast between £24m and £24.5m, compared to £18.2m in the first half of 2024.
The AIM-traded woundcare and surgical technology specialist said the integration of Peters Surgical and Syntacoll was progressing well, with initial commercial synergies already contributing to surgical sales growth.
It said the restructuring of its woundcare division, completed in March, had started to deliver improved margins in the second quarter.
"One year on from successfully completing the acquisition of Peters Surgical, it is a good moment to take stock of the excellent integration progress to date, both operationally and in terms of strategic alignment," said chief executive Chris Meredith.
"On the commercial front, we have been pleased to see early synergies already beginning to translate into top-line growth."
Meredith added that the firm's restructured woundcare business had entered a new phase, and was now making a steady contribution to the group.
"Underpinned by our core surgical product portfolio, we are pressing ahead to deliver strong growth at the group level."
The company said it was on track to meet full-year consensus forecasts, and would report interim results on 17 September.
At 1302 BST, shares in Advanced Medical Solutions Group were up 2.4% at 206.85p.
Reporting by Josh White for Sharecast.com.
